BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33974079)

  • 1. Survival of brain tumour patients with epilepsy.
    Mastall M; Wolpert F; Gramatzki D; Imbach L; Becker D; Schmick A; Hertler C; Roth P; Weller M; Wirsching HG
    Brain; 2021 Dec; 144(11):3322-3327. PubMed ID: 33974079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of epilepsy at presentation in glioblastoma patients.
    Berendsen S; Varkila M; Kroonen J; Seute T; Snijders TJ; Kauw F; Spliet WG; Willems M; Poulet C; Broekman ML; Bours V; Robe PA
    Neuro Oncol; 2016 May; 18(5):700-6. PubMed ID: 26420896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Factors in Glioblastoma: Is There a Role for Epilepsy?
    Dobran M; Nasi D; Chiriatti S; Gladi M; Somma LD; Iacoangeli M; Scerrati M
    Neurol Med Chir (Tokyo); 2018 Mar; 58(3):110-115. PubMed ID: 29343677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common genetic variations of deiodinase genes and prognosis of brain tumor patients.
    Bunevicius A; Laws ER; Saudargiene A; Tamasauskas A; Iervasi G; Deltuva V; Smith TR; Bunevicius R
    Endocrine; 2019 Dec; 66(3):563-572. PubMed ID: 31452060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.
    Happold C; Gorlia T; Chinot O; Gilbert MR; Nabors LB; Wick W; Pugh SL; Hegi M; Cloughesy T; Roth P; Reardon DA; Perry JR; Mehta MP; Stupp R; Weller M
    J Clin Oncol; 2016 Mar; 34(7):731-9. PubMed ID: 26786929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of epilepsy in glioblastomas.
    Toledo M; Sarria-Estrada S; Quintana M; Maldonado X; Martinez-Ricarte F; Rodon J; Auger C; Salas-Puig J; Santamarina E; Martinez-Saez E
    Clin Neurol Neurosurg; 2015 Dec; 139():166-71. PubMed ID: 26489387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme.
    Rosati A; Poliani PL; Todeschini A; Cominelli M; Medicina D; Cenzato M; Simoncini EL; Magrini SM; Buglione M; Grisanti S; Padovani A
    Neuro Oncol; 2013 May; 15(5):618-25. PubMed ID: 23410662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Concomitant meningioma and glioblastoma. Report of a case].
    Martins Antunes AC; Ferreira Coutinho M; Barbosa Coutinho LM
    Arq Neuropsiquiatr; 1978 Sep; 36(3):265-9. PubMed ID: 210746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor activity and clinical outcome in glioblastoma and meningioma.
    Dorward NL; Hawkins RA; Whittle IR
    Br J Neurosurg; 1993; 7(2):197-9. PubMed ID: 8388222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical meningioma. A study on recurrence and disease-specific survival.
    Champeaux C; Houston D; Dunn L
    Neurochirurgie; 2017 Sep; 63(4):273-281. PubMed ID: 28882609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of seizure timing on long-term survival in patients with brain tumor.
    Wasade VS; Viarasilpa T; Balki I; Osman G; Gaddam A; Dharaiya D; Pellumbi N; Snyder J; Walbert T; Spanaki M; Schultz L
    Epilepsy Behav; 2020 Oct; 111():107307. PubMed ID: 32693378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain tumour surgery in the elderly: a brief reappraisal.
    Bernstein M
    Can J Surg; 1996 Apr; 39(2):147-50. PubMed ID: 8769926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and histopathological predictors of outcome in malignant meningioma.
    Maier AD; Bartek J; Eriksson F; Ugleholdt H; Juhler M; Broholm H; Mathiesen TI
    Neurosurg Rev; 2020 Apr; 43(2):643-653. PubMed ID: 30868425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant Meningioma: An International Multicentre Retrospective Study.
    Champeaux C; Jecko V; Houston D; Thorne L; Dunn L; Fersht N; Khan AA; Resche-Rigon M
    Neurosurgery; 2019 Sep; 85(3):E461-E469. PubMed ID: 30566646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningioma and breast cancer: survival of patients with synchronous and metachronous meningioma and breast cancer.
    Lavrador JP; Pinto MV; Lemos LM; Ribeiro C; Santos AP
    J Neurooncol; 2018 Jan; 136(1):163-171. PubMed ID: 29119423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting outcome of epilepsy after meningioma resection.
    Wirsching HG; Morel C; Gmür C; Neidert MC; Baumann CR; Valavanis A; Rushing EJ; Krayenbühl N; Weller M
    Neuro Oncol; 2016 Jul; 18(7):1002-10. PubMed ID: 26683139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the choice of antiepileptic drug affect survival in glioblastoma patients?
    Knudsen-Baas KM; Engeland A; Gilhus NE; Storstein AM; Owe JF
    J Neurooncol; 2016 Sep; 129(3):461-469. PubMed ID: 27377653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Simultaneous occurrence of brain tumors and aneurysms].
    Plangger CA; Twerdy K; Mohsenipour I; Grunert V
    Nervenarzt; 1987 Apr; 58(5):279-86. PubMed ID: 3037397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frequency of brain tumors in epileptic patients].
    Escobedo Ríos F; Sotelo J; Rubio Donnadieu F
    Salud Publica Mex; 1981; 23(3):269-73. PubMed ID: 6274048
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients.
    Bunevicius A; Radziunas A; Tamasauskas S; Tamasauskas A; Laws ER; Iervasi G; Bunevicius R; Deltuva V
    J Neurooncol; 2018 Jun; 138(2):351-358. PubMed ID: 29460097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.